Literature DB >> 11856559

Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia.

Martha Escobar1, Philippe Oberling, Ralph R Miller.   

Abstract

Latent inhibition (attenuated responding to a signal due to signal-alone presentations preceding the signal-outcome pairings) and blocking (attenuated responding to Signal B due to Signal A being paired with the outcome prior to pairings of an AB compound with the outcome) are reportedly absent in acute schizophrenics. The common assumption that these phenomena reflect the normal functioning of attention and the observation that rats administered low doses of amphetamine show a similar disruption has resulted in the development of an animal model of attentional dysfunction in acute schizophrenia. Here, we selectively review the experimental and clinical literature concerning latent inhibition and blocking, their disruption in acute schizophrenia, and the current status of this model. We conclude that the construct validity of the model is compromised if latent inhibition and blocking are viewed in attentional terms because experimental data indicate both phenomena can be better understood in associative terms. We favor a framework in which disruption of latent inhibition and blocking in acute schizophrenics is viewed as an inability to compare and express stored representations (i.e. associative performance deficit). This change of perspective does not undermine the potential value of the model, but rather suggests that the nature of its validity should be reconsidered.

Entities:  

Mesh:

Year:  2002        PMID: 11856559     DOI: 10.1016/s0149-7634(01)00067-7

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  15 in total

1.  Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition.

Authors:  E Diaz; J Medellín; N Sánchez; J P Vargas; J C López
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

Review 2.  There is a time and a place for everything: bidirectional modulations of latent inhibition by time-induced context differentiation.

Authors:  R E Lubow; L G De la Casa
Journal:  Psychon Bull Rev       Date:  2005-10

Review 3.  Determinants of cue interactions.

Authors:  Daniel S Wheeler; Ralph R Miller
Journal:  Behav Processes       Date:  2008-02-08       Impact factor: 1.777

4.  The visual search analogue of latent inhibition: implications for theories of irrelevant stimulus processing in normal and schizophrenic groups.

Authors:  R E Lubow; Oren Kaplan
Journal:  Psychon Bull Rev       Date:  2005-04

5.  Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD.

Authors:  Kristy J Bruno; Christopher S Freet; Robert C Twining; Kiyoshi Egami; Patricia S Grigson; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2006-10-24       Impact factor: 5.996

6.  Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.

Authors:  Catherine C Tenn; Shitij Kapur; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2005-04-26       Impact factor: 4.530

7.  Transient disruption of attentional performance following escalating amphetamine administration in rats.

Authors:  Robyn L Kondrad; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

8.  Appetitive latent inhibition in rats: now you see it (sign tracking), now you don't (goal tracking).

Authors:  Robert L Boughner; Mauricio R Papini
Journal:  Learn Behav       Date:  2003-11       Impact factor: 1.986

Review 9.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

10.  A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease.

Authors:  Orsolya Györfi; Helga Nagy; Magdolna Bokor; Oguz Kelemen; Szabolcs Kéri
Journal:  J Neural Transm (Vienna)       Date:  2016-10-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.